361 related articles for article (PubMed ID: 19061695)
1. Rationale, design, and baseline characteristics of a Program to Assess and Review Trending INformation and Evaluate CorRelation to Symptoms in Patients with Heart Failure (PARTNERS HF).
Whellan DJ; O'Connor CM; Ousdigian KT; Lung TH;
Am Heart J; 2008 Nov; 156(5):833-9, 839.e2. PubMed ID: 19061695
[TBL] [Abstract][Full Text] [Related]
2. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study.
Whellan DJ; Ousdigian KT; Al-Khatib SM; Pu W; Sarkar S; Porter CB; Pavri BB; O'Connor CM;
J Am Coll Cardiol; 2010 Apr; 55(17):1803-10. PubMed ID: 20413029
[TBL] [Abstract][Full Text] [Related]
3. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.
Saxon LA; Greenfield RA; Crandall BG; Nydegger CC; Orlov M; VAN Genderen R
J Cardiovasc Electrophysiol; 2006 May; 17(5):520-5. PubMed ID: 16684026
[TBL] [Abstract][Full Text] [Related]
4. Impact of upgrade to cardiac resynchronization therapy on ventricular arrhythmia frequency in patients with implantable cardioverter-defibrillators.
Ermis C; Seutter R; Zhu AX; Benditt LC; VanHeel L; Sakaguchi S; Lurie KG; Lu F; Benditt DG
J Am Coll Cardiol; 2005 Dec; 46(12):2258-63. PubMed ID: 16360055
[TBL] [Abstract][Full Text] [Related]
5. Fundamentals of intrathoracic impedance monitoring in heart failure.
Wang L
Am J Cardiol; 2007 May; 99(10A):3G-10G. PubMed ID: 17512421
[TBL] [Abstract][Full Text] [Related]
6. Pacing Evaluation-Atrial SUpport Study in Cardiac Resynchronization Therapy (PEGASUS CRT): design and rationale.
Martin DO; Stolen KQ; Brown S; Yu Y; Christie C; Doshi SK; Smith JM; Gold MR; Day JD
Am Heart J; 2007 Jan; 153(1):7-13. PubMed ID: 17174627
[TBL] [Abstract][Full Text] [Related]
7. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure.
Ghali JK; Boehmer J; Feldman AM; Saxon LA; Demarco T; Carson P; Yong P; Galle EG; Leigh J; Ecklund FL; Bristow MR
J Card Fail; 2007 Nov; 13(9):769-73. PubMed ID: 17996827
[TBL] [Abstract][Full Text] [Related]
8. Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF).
Braunschweig F; Ford I; Conraads V; Cowie MR; Jondeau G; Kautzner J; Lunati M; Munoz Aguilera R; Man Yu C; Marijianowski M; Borggrefe M; van Veldhuisen DJ;
Eur J Heart Fail; 2008 Sep; 10(9):907-16. PubMed ID: 18715826
[TBL] [Abstract][Full Text] [Related]
9. Rationale and design of a prospective trial to assess the sensitivity and positive predictive value of implantable intrathoracic impedance monitoring in the prediction of heart failure hospitalizations: the SENSE-HF study.
Cowie MR; Conraads V; Tavazzi L; Yu CM;
J Card Fail; 2009 Jun; 15(5):394-400. PubMed ID: 19477399
[TBL] [Abstract][Full Text] [Related]
10. Continuous monitoring of intrathoracic impedance and right ventricular pressures in patients with heart failure.
Vanderheyden M; Houben R; Verstreken S; Ståhlberg M; Reiters P; Kessels R; Braunschweig F
Circ Heart Fail; 2010 May; 3(3):370-7. PubMed ID: 20197559
[TBL] [Abstract][Full Text] [Related]
11. Remote Active Monitoring in Patients with Heart Failure (RAPID-RF): design and rationale.
Saxon LA; Boehmer JP; Neuman S; Mullin CM
J Card Fail; 2007 May; 13(4):241-6. PubMed ID: 17517341
[TBL] [Abstract][Full Text] [Related]
12. Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF.
Yancy CW; Fonarow GC; Albert NM; Curtis AB; Stough WG; Gheorghiade M; Heywood JT; McBride ML; Mehra MR; O'Connor CM; Reynolds D; Walsh MN
Am Heart J; 2009 Apr; 157(4):754-62.e2. PubMed ID: 19332206
[TBL] [Abstract][Full Text] [Related]
13. Development of a method to risk stratify patients with heart failure for 30-day readmission using implantable device diagnostics.
Whellan DJ; Sarkar S; Koehler J; Small RS; Boyle A; Warman EN; Abraham WT
Am J Cardiol; 2013 Jan; 111(1):79-84. PubMed ID: 23040596
[TBL] [Abstract][Full Text] [Related]
14. Relationship between New York Heart Association class change and ventricular tachyarrhythmia occurrence in patients treated with cardiac resynchronization plus defibrillator.
Lepillier A; Piot O; Gerritse B; Copie X; Lavergne T; Paziaud O; Lascault G; Waintraub X; Otmani A; Le Heuzey JY
Europace; 2009 Jan; 11(1):80-5. PubMed ID: 18952828
[TBL] [Abstract][Full Text] [Related]
15. How well are chronic heart failure patients being managed?
Fonarow GC
Rev Cardiovasc Med; 2006; 7 Suppl 1():S3-11. PubMed ID: 16955055
[TBL] [Abstract][Full Text] [Related]
16. Economic analysis of a randomized trial of biventricular pacing in Canada.
Bentkover JD; Dorian P; Thibault B; Gardner M
Pacing Clin Electrophysiol; 2007 Jan; 30(1):38-43. PubMed ID: 17241313
[TBL] [Abstract][Full Text] [Related]
17. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study.
Bourge RC; Abraham WT; Adamson PB; Aaron MF; Aranda JM; Magalski A; Zile MR; Smith AL; Smart FW; O'Shaughnessy MA; Jessup ML; Sparks B; Naftel DL; Stevenson LW;
J Am Coll Cardiol; 2008 Mar; 51(11):1073-9. PubMed ID: 18342224
[TBL] [Abstract][Full Text] [Related]
18. Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry.
Shah B; Hernandez AF; Liang L; Al-Khatib SM; Yancy CW; Fonarow GC; Peterson ED;
J Am Coll Cardiol; 2009 Feb; 53(5):416-22. PubMed ID: 19179199
[TBL] [Abstract][Full Text] [Related]
19. The Managed Ventricular pacing versus VVI 40 Pacing (MVP) Trial: clinical background, rationale, design, and implementation.
Sweeney MO; Ellenbogen KA; Miller EH; Sherfesee L; Sheldon T; Whellan D
J Cardiovasc Electrophysiol; 2006 Dec; 17(12):1295-8. PubMed ID: 17081208
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators.
Pietrasik G; Goldenberg I; McNitt S; Polonsky B; Moss AJ; Zareba W
J Cardiovasc Electrophysiol; 2009 Apr; 20(4):395-400. PubMed ID: 19017351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
